Cargando…

(μ-2,2′,2′′,2′′′-{[Pyrazine-2,3,5,6-tetra­yltetra­kis(methyl­ene)]tetra­kis(sulfanedi­yl)}tetra­acetato)bis­[aqua­nickel(II)] hepta­hydrate

Reaction of the ligand 2,2′,2′′,2′′′-{[pyrazine-2,3,5,6-tetra­yltetra­kis­(methyl­ene)]tetra­kis­(sulfanedi­yl)}tetra­acetic acid (H(4)L1), with NiCl(2) leads to the formation of a binuclear complex, (μ-2,2′,2′′,2′′′-{[pyrazine-2,3,5,6-tetra­yltetra­kis­(methyl­ene)]tetra­kis­(sulfanedi­yl)}tetra­ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Pacifico, Jessica, Stoeckli-Evans, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462308/
https://www.ncbi.nlm.nih.gov/pubmed/36337591
http://dx.doi.org/10.1107/S2414314621012955
_version_ 1784787156799062016
author Pacifico, Jessica
Stoeckli-Evans, Helen
author_facet Pacifico, Jessica
Stoeckli-Evans, Helen
author_sort Pacifico, Jessica
collection PubMed
description Reaction of the ligand 2,2′,2′′,2′′′-{[pyrazine-2,3,5,6-tetra­yltetra­kis­(methyl­ene)]tetra­kis­(sulfanedi­yl)}tetra­acetic acid (H(4)L1), with NiCl(2) leads to the formation of a binuclear complex, (μ-2,2′,2′′,2′′′-{[pyrazine-2,3,5,6-tetra­yltetra­kis­(methyl­ene)]tetra­kis­(sulfanedi­yl)}tetra­acetato-κ(5) O,S,N (1),S′,O′:κ(5) O′′,S′′,N (4),S′′′,O′′′)bis[aqua­nickel(II)] hepta­hydrate, {[Ni(2)(C(16)H(16)N(2)O(8)S(4))(H(2)O)(2)]·7H(2)O} (I). It crystallizes with two half mol­ecules in the asymmetric unit. The complete mol­ecules are generated by inversion symmetry, with the center of the pyrazine rings being located at crystallographic centres of inversion. The ligand coordinates two Ni(II) ions in a bis-penta­dentate manner and the sixfold coordination sphere of each nickel(II) atom (NiS(2)O(3)N) is completed by a water mol­ecule. The complex crystallized as a hepta-hydrate. The binuclear complexes are linked by O(water)—H⋯O(carbon­yl) hydrogen bonds, forming layers parallel to the (101) plane. This layered structure is additionally stabilized by weak C—H⋯O hydrogen bonds. Further O—H⋯O hydrogen bonds involving binuclear complexes and solvent water mol­ecules, together with weak C—H⋯S hydrogen bonds, link the layers to form a supra­molecular framework. [Image: see text]
format Online
Article
Text
id pubmed-9462308
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-94623082022-11-04 (μ-2,2′,2′′,2′′′-{[Pyrazine-2,3,5,6-tetra­yltetra­kis(methyl­ene)]tetra­kis(sulfanedi­yl)}tetra­acetato)bis­[aqua­nickel(II)] hepta­hydrate Pacifico, Jessica Stoeckli-Evans, Helen IUCrdata Data Reports Reaction of the ligand 2,2′,2′′,2′′′-{[pyrazine-2,3,5,6-tetra­yltetra­kis­(methyl­ene)]tetra­kis­(sulfanedi­yl)}tetra­acetic acid (H(4)L1), with NiCl(2) leads to the formation of a binuclear complex, (μ-2,2′,2′′,2′′′-{[pyrazine-2,3,5,6-tetra­yltetra­kis­(methyl­ene)]tetra­kis­(sulfanedi­yl)}tetra­acetato-κ(5) O,S,N (1),S′,O′:κ(5) O′′,S′′,N (4),S′′′,O′′′)bis[aqua­nickel(II)] hepta­hydrate, {[Ni(2)(C(16)H(16)N(2)O(8)S(4))(H(2)O)(2)]·7H(2)O} (I). It crystallizes with two half mol­ecules in the asymmetric unit. The complete mol­ecules are generated by inversion symmetry, with the center of the pyrazine rings being located at crystallographic centres of inversion. The ligand coordinates two Ni(II) ions in a bis-penta­dentate manner and the sixfold coordination sphere of each nickel(II) atom (NiS(2)O(3)N) is completed by a water mol­ecule. The complex crystallized as a hepta-hydrate. The binuclear complexes are linked by O(water)—H⋯O(carbon­yl) hydrogen bonds, forming layers parallel to the (101) plane. This layered structure is additionally stabilized by weak C—H⋯O hydrogen bonds. Further O—H⋯O hydrogen bonds involving binuclear complexes and solvent water mol­ecules, together with weak C—H⋯S hydrogen bonds, link the layers to form a supra­molecular framework. [Image: see text] International Union of Crystallography 2021-12-09 /pmc/articles/PMC9462308/ /pubmed/36337591 http://dx.doi.org/10.1107/S2414314621012955 Text en © Pacifico and Stoeckli-Evans 2021 https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Data Reports
Pacifico, Jessica
Stoeckli-Evans, Helen
(μ-2,2′,2′′,2′′′-{[Pyrazine-2,3,5,6-tetra­yltetra­kis(methyl­ene)]tetra­kis(sulfanedi­yl)}tetra­acetato)bis­[aqua­nickel(II)] hepta­hydrate
title (μ-2,2′,2′′,2′′′-{[Pyrazine-2,3,5,6-tetra­yltetra­kis(methyl­ene)]tetra­kis(sulfanedi­yl)}tetra­acetato)bis­[aqua­nickel(II)] hepta­hydrate
title_full (μ-2,2′,2′′,2′′′-{[Pyrazine-2,3,5,6-tetra­yltetra­kis(methyl­ene)]tetra­kis(sulfanedi­yl)}tetra­acetato)bis­[aqua­nickel(II)] hepta­hydrate
title_fullStr (μ-2,2′,2′′,2′′′-{[Pyrazine-2,3,5,6-tetra­yltetra­kis(methyl­ene)]tetra­kis(sulfanedi­yl)}tetra­acetato)bis­[aqua­nickel(II)] hepta­hydrate
title_full_unstemmed (μ-2,2′,2′′,2′′′-{[Pyrazine-2,3,5,6-tetra­yltetra­kis(methyl­ene)]tetra­kis(sulfanedi­yl)}tetra­acetato)bis­[aqua­nickel(II)] hepta­hydrate
title_short (μ-2,2′,2′′,2′′′-{[Pyrazine-2,3,5,6-tetra­yltetra­kis(methyl­ene)]tetra­kis(sulfanedi­yl)}tetra­acetato)bis­[aqua­nickel(II)] hepta­hydrate
title_sort (μ-2,2′,2′′,2′′′-{[pyrazine-2,3,5,6-tetra­yltetra­kis(methyl­ene)]tetra­kis(sulfanedi­yl)}tetra­acetato)bis­[aqua­nickel(ii)] hepta­hydrate
topic Data Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462308/
https://www.ncbi.nlm.nih.gov/pubmed/36337591
http://dx.doi.org/10.1107/S2414314621012955
work_keys_str_mv AT pacificojessica m2222pyrazine2356tetrayltetrakismethylenetetrakissulfanediyltetraacetatobisaquanickeliiheptahydrate
AT stoecklievanshelen m2222pyrazine2356tetrayltetrakismethylenetetrakissulfanediyltetraacetatobisaquanickeliiheptahydrate